Lipocine Inc Common (LPCN) 3.69 $LPCN
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN) And Reminds Investors with Losses to Contact the Firm
GlobeNewswire - Fri Jul 29, 8:00PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(Nasdaq:LPCN) in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine common stock between June 30, 2015 and June 28, 2016, inclusive (the "Class Period", seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act".
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN
GlobeNewswire - Fri Jul 29, 7:00PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ:LPCN), and certain of the company's officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons other than Defendants who purchased or acquired Lipocine securities between June 30, 2015 and June 28, 2016, both dates inclusive (collectively, the "Class Period", seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" and Rule 10b-5 promulgated thereunder.
LPCN: 3.69 (+0.09)
August 30th Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of Deadline in the Class Action Lawsuit Against Lipocine Inc.
BusinessWire - Fri Jul 29, 12:47PM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming August 30, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) securities between February 27, 2015 and June 28, 2016, inclusive (the "Class Period".
LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jul 28, 7:45PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 28, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit - LPCN
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine Inc. (Nasdaq:LPCN) ("Lipocine" or the "Company" securities during the period between June 30, 2015 and June 28, 2016, inclusive (the "Class Period". Investors who wish to become proactively involved in the litigation have until August 30, 2016 to seek appointment as lead plaintiff.
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline: August 30, 2016
ACCESSWIRE - Thu Jul 28, 11:16AM CDT
NEW YORK, NY / ACCESSWIRE / July 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period".
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. and Encourages Investors With Losses to Contact the Firm
BusinessWire - Tue Jul 26, 4:51PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN). Investors who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 (the "Class Period" are encouraged to contact the firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.69 (+0.09)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN
GlobeNewswire - Tue Jul 26, 9:04AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc. (NASDAQ:LPCN) securities between June 30, 2015 and June 28, 2016.
LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 25, 10:41AM CDT
IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.69 (+0.09)
Lawsuit for Investors in shares of Lipocine Inc (NASDAQ:LPCN) announced by Shareholders Foundation
GlobeNewswire - Mon Jul 25, 9:15AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit was filed in New Jersey on behalf of certain purchasers of shares of Lipocine Inc (NASDAQ:LPCN) over alleged Securities Laws Violations by Lipocine Inc. The lawsuit seeks to recover damages for certain NASDAQ:LPCN investors.
LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Mon Jul 18, 6:18PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 18, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.69 (+0.09)
SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lipocine Inc. Investors of Important Deadline in Class Action Filed by Firm - LPCN
BusinessWire - Mon Jul 18, 5:20PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lipocine Inc. securities (NASDAQ:LPCN) from June 30, 2015 through June 28, 2016, inclusive (the "Class Period" of the important August 30, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Lipocine investors under the federal securities laws.
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN
PR Newswire - Fri Jul 15, 3:30PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN), and certain of the company's officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons other than Defendants who purchased or acquired Lipocine securities between June 30, 2015 and June 28, 2016, both dates inclusive (collectively, the "Class Period", seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" and Rule 10b-5 promulgated thereunder.
LPCN: 3.69 (+0.09)
IMPORTANT LIPOCINE, INC. SHAREHOLDER UPDATE: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors that a Class Action Lawsuit with an Expanded Class Period has been Commenced on Behalf of Shareholders of Lipocine, Inc.
ACCESSWIRE - Thu Jul 14, 4:30PM CDT
Lead Plaintiff Deadline is August 30, 2016
LPCN: 3.69 (+0.09)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 -- LPCN
Marketwire Canada - Tue Jul 12, 9:50AM CDT
NEW YORK, NY--(Marketwired - July 12, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:
LPCN: 3.69 (+0.09)
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN)
GlobeNewswire - Mon Jul 11, 7:00PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (Nasdaq:LPCN) in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine common stock between June 30, 2015 and June 28, 2016, inclusive (the "Class Period", seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act".
LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Lipocine Inc. and Reminds Investors With Losses to Contact the Firm
BusinessWire - Sat Jul 09, 5:40PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq:LPCN). Investors who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline.
LPCN: 3.69 (+0.09)
IMPORTANT LIPOCINE, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors That a Class Action Lawsuit Has Been Commenced on Behalf of Shareholders of Lipocine, Inc.
ACCESSWIRE - Fri Jul 08, 4:52PM CDT
Lead Plaintiff Deadline Is August 30, 2016
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline August 30, 2016
ACCESSWIRE - Fri Jul 08, 9:25AM CDT
NEW YORK, NY / ACCESSWIRE / July 8, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period".
LPCN: 3.69 (+0.09)
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN) And Reminds Investors with Losses to Contact the Firm
GlobeNewswire - Fri Jul 29, 8:00PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(Nasdaq:LPCN) in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine common stock between June 30, 2015 and June 28, 2016, inclusive (the "Class Period", seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act". LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN
GlobeNewswire - Fri Jul 29, 7:00PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company"
(NASDAQ:LPCN), and certain of the company's officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons other than Defendants who purchased or acquired Lipocine securities between June 30, 2015 and June 28, 2016, both dates inclusive (collectively, the "Class Period", seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" and Rule 10b-5 promulgated thereunder. LPCN: 3.69 (+0.09)
August 30th Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of Deadline in the Class Action Lawsuit Against Lipocine Inc.
BusinessWire - Fri Jul 29, 12:47PM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming August 30, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class"
of investors who purchased Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN) securities between February 27, 2015 and June 28, 2016, inclusive (the "Class Period". LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jul 28, 7:45PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 28, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit - LPCN
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine Inc. (Nasdaq:LPCN) ("Lipocine" or the "Company"
securities during the period between June 30, 2015 and June 28, 2016, inclusive (the "Class Period". Investors who wish to become proactively involved in the litigation have until August 30, 2016 to seek appointment as lead plaintiff. LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline: August 30, 2016
ACCESSWIRE - Thu Jul 28, 11:16AM CDT
NEW YORK, NY / ACCESSWIRE / July 28, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period". LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. and Encourages Investors With Losses to Contact the Firm
BusinessWire - Tue Jul 26, 4:51PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company"
(Nasdaq: LPCN). Investors who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 (the "Class Period" are encouraged to contact the firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.69 (+0.09)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Lipocine Inc. and a Lead Plaintiff Deadline of August 30, 2016 - LPCN
GlobeNewswire - Tue Jul 26, 9:04AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc. (NASDAQ:LPCN) securities between June 30, 2015 and June 28, 2016.
LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 25, 10:41AM CDT
IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Lipocine Inc. ("Lipocine" or the "Company" (NASDAQ: LPCN). Investors who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.69 (+0.09)
Lawsuit for Investors in shares of Lipocine Inc (NASDAQ:LPCN) announced by Shareholders Foundation
GlobeNewswire - Mon Jul 25, 9:15AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit was filed in New Jersey on behalf of certain purchasers of shares of Lipocine Inc (NASDAQ:LPCN) over alleged Securities Laws Violations by Lipocine Inc. The lawsuit seeks to recover damages for certain NASDAQ:LPCN investors.
LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Mon Jul 18, 6:18PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 18, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company"
(Nasdaq: LPCN) concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.69 (+0.09)
SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lipocine Inc. Investors of Important Deadline in Class Action Filed by Firm - LPCN
BusinessWire - Mon Jul 18, 5:20PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lipocine Inc. securities (NASDAQ:LPCN) from June 30, 2015 through June 28, 2016, inclusive (the "Class Period"
of the important August 30, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Lipocine investors under the federal securities laws. LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN
PR Newswire - Fri Jul 15, 3:30PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company"
(NASDAQ: LPCN), and certain of the company's officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons other than Defendants who purchased or acquired Lipocine securities between June 30, 2015 and June 28, 2016, both dates inclusive (collectively, the "Class Period", seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" and Rule 10b-5 promulgated thereunder. LPCN: 3.69 (+0.09)
IMPORTANT LIPOCINE, INC. SHAREHOLDER UPDATE: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors that a Class Action Lawsuit with an Expanded Class Period has been Commenced on Behalf of Shareholders of Lipocine, Inc.
ACCESSWIRE - Thu Jul 14, 4:30PM CDT
Lead Plaintiff Deadline is August 30, 2016
LPCN: 3.69 (+0.09)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lipocine Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 30, 2016 -- LPCN
Marketwire Canada - Tue Jul 12, 9:50AM CDT
NEW YORK, NY--(Marketwired - July 12, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:
LPCN: 3.69 (+0.09)
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lipocine, Inc. (LPCN)
GlobeNewswire - Mon Jul 11, 7:00PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(Nasdaq:LPCN) in the United States District Court for the District of New Jersey on behalf of purchasers of Lipocine common stock between June 30, 2015 and June 28, 2016, inclusive (the "Class Period", seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act". LPCN: 3.69 (+0.09)
IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Lipocine Inc. and Reminds Investors With Losses to Contact the Firm
BusinessWire - Sat Jul 09, 5:40PM CDT
Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Lipocine Inc. ("Lipocine" or the "Company" (Nasdaq:LPCN). Investors who purchased or otherwise acquired shares between June 30, 2015 and June 28, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 30, 2016 lead plaintiff motion deadline. LPCN: 3.69 (+0.09)
IMPORTANT LIPOCINE, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors That a Class Action Lawsuit Has Been Commenced on Behalf of Shareholders of Lipocine, Inc.
ACCESSWIRE - Fri Jul 08, 4:52PM CDT
Lead Plaintiff Deadline Is August 30, 2016
LPCN: 3.69 (+0.09)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action against Lipocine, Inc. (LPCN) and Lead Plaintiff Deadline August 30, 2016
ACCESSWIRE - Fri Jul 08, 9:25AM CDT
NEW YORK, NY / ACCESSWIRE / July 8, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Lipocine, Inc. ("Lipocine" or the "Company"
(NASDAQ: LPCN) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Lipocine securities between June 30, 2015 through June 28, 2016, both dates inclusive (the "Class Period". LPCN: 3.69 (+0.09)
